2Q18

SINGAPORE (Aug 29): Koufu Group reported 2Q18 earnings of $6.2 million, down by 2.6% from $6.3 million a year ago on higher property-related expenses and depreciation charges.

SINGAPORE (Aug 29): CGS-CIMB Research is maintaining its “add” recommendation on IHH Healthcare with a lower target price of RM6.63 ($2.21) compared to RM6.86 previously, even as the dual-listed Malaysian private healthcare operator’s 2H18 results m

SINGAPORE (Aug 23): Nam Cheong swung back to profitability in 1H18 with earnings of RM0.6 million ($0.2 million) compared to its RM2.1 billion loss in 1H17 after restructuring a substantial amount of trade debts with its creditors, resulting in a waiver o

SINGAPORE (Aug 15): Clearbridge Health announced a loss of $12.2 million for the 2Q ended June, widening from the $0.2 loss it posted a year ago mainly due to fair value losses recorded during the quarter under review.

SINGAPORE (Aug 15): Spackman Entertainment Group reported a loss of US$1.5 million ($2.1 million) for the 2Q ended June, widening from its 2Q17 loss of US$0.2 million on lower revenue and higher general & administrative expenses.

SINGAPORE (Aug 14): IFS Capital has posted earnings of $0.8 million for 2Q18, representing an eightfold surge from its 2Q17 earnings of $0.1 million on lower allowances

SINGAPORE (Aug 13): United Global reported earnings of US$0.9 million ($1.24 million) for the 2Q ended June, halving from its 2Q17 earnings of US$2 million on higher administrative expenses.

SINGAPORE (Aug 13): RHB is maintaining “buy” on HRnetGroup with an unchanged target price of $1.18.

SINGAPORE (Aug 13): The Ministry of Trade and Industry (MTI) expects Singapore’s economic pace of expansion to moderate in 2H18 against an external backdrop of a weakening global growth outlook, as well as increased uncertainties and risks in the global

SINGAPORE (Aug 10): City Developments (CDL) announced earnings of $204.8 million for the 2Q ended June, up 79.5% from its 2Q17 earnings of $114.1 million a year ago, backed by stronger sales recognition during the period under review.